Intellicure

Practice Settings

Mobile wound care

Round through homes and facilities, chart in the hallway.

Hospital wound center

Outpatient volume, hyperbarics, and audit-proof documentation.

Private practice

The full EHR plus scheduling, charge capture, and billing.

Nursing facilities

Documentation, wound healing tracking, and care suggestions for nursing facility staff.

Platform

IntellicureEHR

The full-spectrum wound care record built for one specialty.

Intellicure App for Hospitals

Wound care inside Epic and Oracle Health via HL7 FHIR.

iMeasure.ai and photos

Snap, measure, and upload to the chart in one motion.

CTP Audit Defender

Skin sub applications checked against coverage as you chart.

MIPS quality benchmarking

Track your MIPS quality measures and see how you compare.

Intellicure Analytics

Real-world wound data for researchers and manufacturers.

Why Intellicure

Optimal reimbursements

Documentation in the format payers reward, every visit.

Proven compliance

Audit-ready documentation, defensible the day it is written.

Faster wound charting

Finish the note before you leave the room.

Better healing rates

Decision support drawn from millions of treated wounds.

Clinical workflows

Automate the labor-intensive parts of the clinic day.

Security and uptime

SOC 2 audited, Azure-backed, 99.9% availability.

Resources

Blog

Practical wound care, reimbursement, and compliance writing.

In the news

Where Intellicure and our clinicians have been covered.

About Intellicure

Who we are and why we only build for wound care.

Our leadership

The clinicians and engineers behind the platform.

US Wound Registry

The evidence base our decision support is built on.

Contact us

Talk to a person, or watch a demonstration.

FDA Approves Changing the Expiration Date of Some IV Fluids Made by Baxter to Help Alleviate Shortages

Baxter IV Fluid Shortage

In the wake of shortages made worse by Hurricane Helene, the Food and Drug Administration (FDA) approved changing the expiration date on multiple types of intravenous and sterile fluids made by Baxter International.  Now, the fluids can be used up to two years after manufacturing instead of the previous one year, but this extension only applies to products manufactured prior to the end of September 2024. This may help alleviate some of the shortages which are affecting care. According to an analysis of health records by Truveta Research, in the wake of Hurricane Helen’s disruptions to the supply chain, “patients visiting emergency departments for dehydration or nausea are half as likely to receive IV fluids,” as reported by CNN.

Baxter International is one of the largest suppliers of IV fluids in the United States with its North Cove facility providing 60% of IV fluid in the USA, according to the American Hospital Association.  There was a shortage of some IV-fluid products in the U.S. even before Hurricane Helene forced the Baxter International’s North Cove facility to close, but the closure of the North Carolina-based facility has made the shortage worse. The company plans to re-open at least part of its North Carolina facility earlier this week, so the company expects new batches of IV and other sterile fluids will be ready in mid- to late-November.

Caroline Fife, MD

Dr. Fife is Co-Founder and Chief Medical Officer of Intellicure, Executive Director of the US Wound Registry, and Editor of Today’s Wound Clinic.

Subscribe to the Intellicure Blog!

Submit the form below to receive email alerts when Intellicure publishes a new blog post! This information will not be shared.

Follow Intellicure

You May Also Like ...